| Mrs Vivian A Ortiz Aponte, PYCOLOGIST | |
|
3 Calle Geronimo Martinez, Altos, Aibonito, PR 00705-3660 | |
| (787) 735-3245 | |
| (787) 735-3245 |
| Full Name | Mrs Vivian A Ortiz Aponte |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 3 Calle Geronimo Martinez, Aibonito, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124169891 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 1336 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Vivian A Ortiz Aponte, PYCOLOGIST Po Box 451, Aibonito, PR 00705-0451 Ph: (787) 735-3245 | Mrs Vivian A Ortiz Aponte, PYCOLOGIST 3 Calle Geronimo Martinez, Altos, Aibonito, PR 00705-3660 Ph: (787) 735-3245 |
News Archive
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.
Diversigen, Inc., the leading provider of comprehensive microbiome analysis services, today announced a strategic partnership with Baylor Miraca Genetics Laboratories, a global leader in genetic testing, to provide their customers access to a broad range of targeted genomics and metabolomics services.
QRxPharma Limited announced today that the United States Patent and Trademark Office issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary dosing algorithm for converting patients from intravenous opioid administration to orally administered MoxDuo IR, thereby more effectively and safely managing acute pain following surgery.
A new study provides the best evidence to date that a psychological intervention program designed for breast cancer patients not only improves their health - it actually increases their chance of survival.
› Verified 6 days ago
Lina Cartagena, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: Carretera 725 Km 3.6 Bo Llanos, Aibonito, PR 00705 Phone: 787-612-8501 | |
Dr. Frances M. Febo Cabrero, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 15 Calle Sgt Gerardo Santiago, Aibonito, PR 00705 Phone: 787-403-2216 Fax: 787-339-2410 | |
Jeisela Suarez Gil, Psychologist Medicare: Not Enrolled in Medicare Practice Location: Barriada San Luis, Calle Nazarret #19, Aibonito, PR 00705 Phone: 787-372-4383 | |
Miss Anabel Gracia, PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: State Road 14 Sargento Santiago Interior, Aibonito, PR 00705 Phone: 787-735-6115 Fax: 787-735-6190 | |
Mrs. Vanessa Vazquez, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 179 Ave Felix Rios, Aibonito, PR 00705 Phone: 787-218-6144 Fax: 787-991-0184 | |
Loreane Mercado Colon, MPSY Psychologist Medicare: Not Enrolled in Medicare Practice Location: Edificio Aor / Local 2-b Calle Baldorioty Norte #165, Aibonito, PR 00705 Phone: 787-327-5294 |